Related to Allergan Pays Pieris $10M Up Front to Exploit Anticalin Technology in Ophthalmology

• Feature Articles: Novel Approaches to Engineer Antibodies
  
• Feature Articles: Surmounting Small Molecule Challenges
  
• Feature Articles: Waging a Multipronged Alzheimer’s War
  
• Feature Articles: Making Improvements to Standard of Care for HCV
  
• Feature Articles: Accelerating Small Molecule Research
  
• Feature Articles: Small Molecule Simplicity Gives Them Staying Power
  
• Point of View: Drug R&D Costs Questioned
  
• BioMarket Trends: Large Molecules Continue to Gain Favor
  
• Feature Articles: New Approaches Redefine Small Molecule Discovery
  
• Feature Articles: Targeting Protein-Protein Interactions
  
• Corporate Profiles: Zapping Pathological Proteins in Alzheimer’s
  
• Corporate Profiles: Exploiting Folate Pathways to Treat Cancer